<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Garcia-Gomez P</submitter><funding>O. E. och Edla Johanssons Vetenskapliga Stiftelse</funding><funding>Svenska Läkaresällskapet</funding><funding>Stiftelsen Lars Hiertas Minne</funding><funding>Magnus Bergvalls Stiftelse</funding><funding>Petrus och Augusta Hedlunds Stiftelse</funding><funding>Ludwig Institute for Cancer Research</funding><funding>Cancerfonden</funding><pagination>1891-1912</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9067149</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(9)</volume><pubmed_abstract>Glioblastoma (GBM) is the most aggressive and common glioma subtype, with a median survival of 15 months after diagnosis. Current treatments have limited therapeutic efficacy; thus, more effective approaches are needed. The glioblastoma tumoural mass is characterised by a small cellular subpopulation - glioblastoma stem cells (GSCs) - that has been held responsible for glioblastoma initiation, cell invasion, proliferation, relapse and resistance to chemo- and radiotherapy. Targeted therapies against GSCs are crucial, as is understanding the molecular mechanisms that govern the GSCs. Transforming growth factor β (TGFβ) signalling and reactive oxygen species (ROS) production are known to govern and regulate cancer stem cell biology. Among the differentially expressed genes regulated by TGFβ in a transcriptomic analysis of two different patient-derived GSCs, we found NADPH oxidase 4 (NOX4) as one of the top upregulated genes. Interestingly, when patient tissues were analysed, NOX4 expression was found to be higher in GSCs versus differentiated cells. A functional analysis of the role of NOX4 downstream of TGFβ in several patient-derived GSCs showed that TGFβ does indeed induce NOX4 expression and increases ROS production in a NOX4-dependent manner. NOX4 downstream of TGFβ regulates GSC proliferation, and NOX4 expression is necessary for TGFβ-induced expression of stem cell markers and of the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2), which in turn controls the cell's antioxidant and metabolic responses. Interestingly, overexpression of NOX4 recapitulates the effects induced by TGFβ in GSCs: enhanced proliferation, stemness and NRF2 expression. In conclusion, this work functionally establishes NOX4 as a key mediator of GSC biology.</pubmed_abstract><journal>Molecular oncology</journal><pubmed_title>NOX4 regulates TGFβ-induced proliferation and self-renewal in glioblastoma stem cells.</pubmed_title><pmcid>PMC9067149</pmcid><funding_grant_id>M2019‐1065</funding_grant_id><funding_grant_id>M2020‐1274</funding_grant_id><funding_grant_id>2019‐03444</funding_grant_id><funding_grant_id>FO2020‐0335</funding_grant_id><funding_grant_id>CAN 2012/1186</funding_grant_id><funding_grant_id>2020‐03781</funding_grant_id><funding_grant_id>SLS‐887701</funding_grant_id><funding_grant_id>CAN 2017/1066</funding_grant_id><pubmed_authors>Tzavlaki K</pubmed_authors><pubmed_authors>Carreras-Puigvert J</pubmed_authors><pubmed_authors>S Dadras M</pubmed_authors><pubmed_authors>Moren A</pubmed_authors><pubmed_authors>Bellomo C</pubmed_authors><pubmed_authors>Golan I</pubmed_authors><pubmed_authors>Garcia-Gomez P</pubmed_authors><pubmed_authors>Mezheyeuski A</pubmed_authors><pubmed_authors>Caja L</pubmed_authors></additional><is_claimable>false</is_claimable><name>NOX4 regulates TGFβ-induced proliferation and self-renewal in glioblastoma stem cells.</name><description>Glioblastoma (GBM) is the most aggressive and common glioma subtype, with a median survival of 15 months after diagnosis. Current treatments have limited therapeutic efficacy; thus, more effective approaches are needed. The glioblastoma tumoural mass is characterised by a small cellular subpopulation - glioblastoma stem cells (GSCs) - that has been held responsible for glioblastoma initiation, cell invasion, proliferation, relapse and resistance to chemo- and radiotherapy. Targeted therapies against GSCs are crucial, as is understanding the molecular mechanisms that govern the GSCs. Transforming growth factor β (TGFβ) signalling and reactive oxygen species (ROS) production are known to govern and regulate cancer stem cell biology. Among the differentially expressed genes regulated by TGFβ in a transcriptomic analysis of two different patient-derived GSCs, we found NADPH oxidase 4 (NOX4) as one of the top upregulated genes. Interestingly, when patient tissues were analysed, NOX4 expression was found to be higher in GSCs versus differentiated cells. A functional analysis of the role of NOX4 downstream of TGFβ in several patient-derived GSCs showed that TGFβ does indeed induce NOX4 expression and increases ROS production in a NOX4-dependent manner. NOX4 downstream of TGFβ regulates GSC proliferation, and NOX4 expression is necessary for TGFβ-induced expression of stem cell markers and of the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2), which in turn controls the cell's antioxidant and metabolic responses. Interestingly, overexpression of NOX4 recapitulates the effects induced by TGFβ in GSCs: enhanced proliferation, stemness and NRF2 expression. In conclusion, this work functionally establishes NOX4 as a key mediator of GSC biology.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-19T12:55:09.429Z</modification><creation>2025-04-19T12:55:09.429Z</creation></dates><accession>S-EPMC9067149</accession><cross_references><pubmed>35203105</pubmed><doi>10.1002/1878-0261.13200</doi></cross_references></HashMap>